investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens

Daniel W Cramer

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Related projects

Lesley M Butler

Urinary Metalloproteinases and Ovarian Cancer Risk in a Prospective Cohort

Ovary

Pathology

Mary Anne Rossing

Epidemiologic Factors and Survival by Molecular Subtypes of Ovarian Cancer

Ovary

Pathology

Simon A Gayther

The Contribution of Rare Alleles to Ovarian Cancer in the Population

Ovary

Pathology

Thomas A Sellers

Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)

Ovary

Pathology

Scott H Kaufmann

Mayo Clinic SPORE in Ovarian Cancer

Ovary

Pathology

Bryan Q Spring

Online monitoring and image-guided treatment of chemoresistant micrometastases

Ovary

Pathology

Susan J Ramus

Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer

Ovary

Pathology

Linda S Cook

Mitochondrial DNA and Ovarian Cancer Risk and Survival

Ovary

Pathology

Multiple Myeloma Study / Histological Classification and Clinical Course of Surface Epithelial Ovarian Tumors in Abuja

Ovary

Pathology